Cytotoxic Activity of Vitex leucoxylon Aqueous Leaf Extract Against A549 and NCIH-460 Lung Cancer Cell Lines
暂无分享,去创建一个
I. Shaikh | M. Ghoneim | M. Mahnashi | S. M. Asdaq | J. Hoskeri | A. Nasreen | A. Khan | U. Muddapur | Tasneem Mohammed | Arun K. Shettar | S. Dafalla | B. A. Mannasaheb
[1] A. Alshabi,et al. A Preliminary Cytotoxicity Study of Fagonia arabica against Breast (MCF-7), Oral (KB-3-1), and Lung Cancer (A-549) Cell Lines: A Study Supported by Molecular Marker Analysis Using Dual Staining Dyes , 2023, Separations.
[2] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[3] A. Alshabi,et al. Apoptotic Cell Death via Activation of DNA Degradation, Caspase-3 Activity, and Suppression of Bcl-2 Activity: An Evidence-Based Citrullus colocynthis Cytotoxicity Mechanism toward MCF-7 and A549 Cancer Cell Lines , 2022, Separations.
[4] A. Alshabi,et al. In Vitro Cytotoxicity and Spectral Analysis-Based Phytochemical Profiling of Methanol Extract of Barleria hochstetteri, and Molecular Mechanisms Underlying Its Apoptosis-Inducing Effect on Breast and Lung Cancer Cell Lines , 2022, Separations.
[5] I. Shaikh,et al. Curcumin-Encapsulated Nanomicelles Improve Cellular Uptake and Cytotoxicity in Cisplatin-Resistant Human Oral Cancer Cells , 2022, Journal of functional biomaterials.
[6] I. Shaikh,et al. Plant-Based Synthesis of Gold Nanoparticles and Theranostic Applications: A Review , 2022, Molecules.
[7] Dianbao Zhang,et al. Ginkgolic Acid Inhibits Proliferation and Migration of Glioblastoma Cells by Inducing Cell Cycle Arrest and Apoptosis , 2021, Science of Advanced Materials.
[8] Jun Ma,et al. Evaluation of Circulating Tumor Cells-DNA Methylated Separation Nano-Polylactic-co-Glycolic Acid Magnetic Beads with Epithelial Cell Adhesion Molecul/Epidermal Growth Factor Receptor Double Antibody Modification and Its Application in Lung Cancer Diagnosis , 2021, Science of Advanced Materials.
[9] S. Mir,et al. Box-Behnken Design Optimization of Etoposide Loaded Nanoemulsion: Formulation Development, Cellular Uptake Analysis and Pharmacokinetic Evaluation , 2021, Science of Advanced Materials.
[10] Jun Huang,et al. Effects of Liposomal Nanoparticles-Mediated miR-126 on Cervical Cancer Cells via Anti-Programmed Cell Death-1/Programmed Death Ligand 1 (PD-1/PD-L1) Signaling , 2021, Science of Advanced Materials.
[11] C. Powell,et al. Global Epidemiology of Lung Cancer , 2019, Annals of global health.
[12] R. Vasan,et al. Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study , 2018, Journal of the National Cancer Institute.
[13] C. Zappa,et al. Non-small cell lung cancer: current treatment and future advances. , 2016, Translational lung cancer research.
[14] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[15] D. Saravanan,et al. An update on prodrugs from natural products. , 2014, Asian Pacific journal of tropical medicine.
[16] P. Parameswaran,et al. Recent advances in marine drug research. , 2013, Biotechnology advances.
[17] A. Mitra,et al. Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes. , 2013, Current pharmaceutical design.
[18] Xianglin Shi,et al. Cancer prevention with promising natural products: mechanisms of action and molecular targets. , 2012, Anti-cancer agents in medicinal chemistry.
[19] L. Ferreira,et al. Cytosolic proteome of Kluyveromyces lactis affected by the multidrug resistance regulating transcription factor KlPdr1p. , 2012, Journal of proteomics.
[20] D. Sathyamurthy,et al. Pharmacognostic evaluation and phytochemical studies on leaves of Vitex leucoxylon Linn. , 2012 .
[21] Cristina Carvalho,et al. Doxorubicin: the good, the bad and the ugly effect. , 2009, Current medicinal chemistry.
[22] S. Capaccioli,et al. Natural compounds for cancer treatment and prevention. , 2009, Pharmacological research.
[23] Ping Yang,et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. , 2008, Mayo Clinic proceedings.
[24] J. Rauha,et al. Natural products in the process of finding new drug candidates. , 2004, Current medicinal chemistry.
[25] T. Kawabe. G2 checkpoint abrogators as anticancer drugs. , 2004, Molecular cancer therapeutics.
[26] T. Sethi. Lung cancer • Introduction , 2002, Thorax.
[27] David Harrington,et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. , 2002, The New England journal of medicine.
[28] David B. Holiday,et al. Taxol-induced cell cycle arrest and apoptosis: dose-response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition. , 2001, Cancer letters.
[29] B. Ravishankar,et al. General pharmacology of Vitex leucoxylon Linn leaves. , 1994, Indian journal of physiology and pharmacology.
[30] D. Trump,et al. A phase II study of taxol in patients with malignant melanoma , 1991, Investigational New Drugs.
[31] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[32] M. Osborne,et al. The in vitro and in vivo reaction at the N7-position of guanine of the ultimate carcinogen derived from benzo[a]pyrene , 1979 .
[33] A. Anderson,et al. Concordance of diets and eating practices in a rural Guatemalan setting with the cancer prevention recommendations of the World Cancer Research Fund: estimates from existing dietary intake. , 2006, Asia Pacific journal of clinical nutrition.
[34] A. L. Udupa,et al. Anti-inflammatory and wound healing activities of the crude alcoholic extract and flavonoids of Vitex leucoxylon. , 1990 .